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Abstract The recognition process of tRNASer and tRNASec by
human seryl-tRNA synthetase (SerRS) was studied using T7
transcripts representing defined regions of human tRNASer or
tRNASec and the influence of the tRNA elements on serylation
and tertiary structure was elucidated. The anticodon arms of
both tRNAs showed no contribution to serylation in contrast to
the acceptor stems and the long extra arms. D and T arms were
only involved in formation of the L-shaped tRNA structure, not
in the recognition process between tRNAs and SerRS. This is the
first report of microhelices adapted from human tRNAs being
aminoacylated by their homologous synthetase.
z 1998 Federation of European Biochemical Societies.
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1. Introduction
The ¢delity of protein biosynthesis is maintained by the
correct interaction of aminoacyl-tRNA synthetases (AaRS)
and their cognate tRNAs. The existing 20 di¡erent aminoac-
yl-tRNA synthetases are divided into two classes, each con-
sisting of 10 members. Class I AaRS share two conserved
sequence motifs HIGH and KMSKS and they contact the
acceptor stems of their tRNAs at the minor groove site. The
characteristics of class II AaRS are one or more of three
structural motifs, contacting the acceptor stems of their
tRNAs at the major groove site [1,2].
The overall three-dimensional structure of tRNAs consists
of the acceptor-T arm axis and the anticodon-D arm axis in a
nearly 90‡ angle to each other. This L-shaped structure in-
volves tertiary interactions of nucleotides in the D and T loop.
However, AaRS cannot use solely this L-shape to discriminate
between single tRNAs. In addition they recognize typical
structural and sequence peculiarities, called identity elements,
of their cognate tRNAs. These elements are mostly present at
the ends of the L-shape structure in the discriminator base
position 73, in the acceptor arm, and in the anticodon loop,
and less frequently in the extra arm [3^9]. For alanine [10,11],
histidine [12] and serine [13,14] tRNAs, the anticodon se-
quence is not required for aminoacylation speci¢city; here
the main identity elements are located in the acceptor stems
and for serine additionally in the long extra arm.
Seryl-tRNA synthetase, a member of class II, is a very un-
usual enzyme compared with the other synthetases because of
its substrate speci¢city. It not only serylates the four tRNASer
isoacceptors but also the selenocysteine-incorporating
tRNASec. These tRNAs di¡er in sequence and structure, but
share one structural element, a distinctive stem-loop structure
located between the anticodon stem and the T stem called the
long extra arm. tRNASer and tRNASec both fold into the L-
shape with the long extra arm uncoupled from the rest of the
molecule [15^17]. tRNASec, however, is unique among all
known tRNAs. Eukaryotic tRNAsSec have a 6 bp long D
stem instead of 3 or 4 bp in normal tRNAs, the acceptor
stem is composed of 9 bp and the T stem of 4 bp [16,17].
Human tRNASec is serylated 10-fold less e⁄ciently than
tRNASer ; the possible reasons for this di¡erence were dis-
cussed earlier [18].
Cusack et al. [19] have studied the tRNA-enzyme interac-
tions in crystals of Thermus thermophilus SerRS with
tRNASer. As expected for class II synthetases, the motif 2
loop of the enzyme interacts with the major groove site of
the acceptor stem of the tRNA. Here it is a ring-ring inter-
action of Phe262 of SerRS with U68 and C69 of the tRNA.
Also, the N2 exocyclic amino group of the discriminator base
G73 is in position to hydrogen bond with Glu258 of the en-
zyme, and several other interactions support the recognition
process between the acceptor stem of the tRNA and SerRS
[19]. The backbone of the long extra arm of tRNASer interacts
with the K-helical coiled-coil arm of the synthetase [20].
Studies with seryl-tRNA synthetase and tRNASer of Esche-
richia coli implied that the acceptor stem, the long extra arm
and the D stem of tRNASer are important for serine identity
[13,21]. Further experiments showed that the long extra arm
of tRNASer makes the largest contribution to aminoacylation
e⁄ciency and that the acceptor stem is the second most im-
portant domain for recognition by SerRS [14]. For the accept-
or stem of E. coli tRNASer, base pairs 1:72 through 5:68 were
identi¢ed to be recognized by E. coli SerRS, with the major
identity elements clustered between positions 2:71 and 4:69
[22].
We have shown recently that the major identity elements
for serylation of human tRNASer and tRNASec with homolo-
gous SerRS are the acceptor stem including the discriminator
base G73 and the long extra arm [23,24]. In another class II
tRNA, such as tRNALeu, which also has a long extra arm, the
replacement of the leucine-speci¢c discriminator base A73 by
the serine-speci¢c G73 converts leucine to serine acceptance
[25]. Especially the exocyclic 2-amino group of G73 is abso-
lutely required for serylation [26]. This is strong evidence for
the importance of the long extra arm and of the acceptor stem
for the recognition process between human tRNASer/tRNASec
and SerRS.
It is of great interest to further investigate the contribution
of discrete domains of human tRNASer and human tRNASec
to the recognition by human SerRS. For this purpose we have
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synthesized several RNAs representing de¢ned domains of
tRNASer and tRNASec, and determined their in vitro amino-
acylation with SerRS, using HeLa S100 extract as synthetase
preparation. For a better understanding of the recognition
process, we have used chemical structure probing of tRNASer
and tRNASec derivatives in order to ¢nd out whether the
intact L-shape or the D-T loop interaction is essential for
serylation. This is the ¢rst report of aminoacylation of mini-
and microhelix substrates derived from human tRNAs with
homologous aminoacyl-tRNA synthetase.
2. Materials and methods
2.1. Materials
L-[3H]Serine (1.04 TBq/mmol) and [Q-32P]ATP (110 TBq/mmol)
were purchased from Amersham-Buchler (Braunschweig, Germany)
and Hartmann Analytics (Braunschweig, Germany). T7 RNA polym-
erase was prepared from an overproducing strain of E. coli kindly
provided by Dr. F.W. Studier, with a protocol adapted from Weber
and Gross [27]. HeLa cytoplasmic S100 extract (5.5 mg/ml), prepared
and dialyzed as described by Dignam et al. [28], was used for amino-
acylations since pure human SerRS is not yet available. DMS was
from Aldrich (Steinheim, Germany), DEPC from Serva (Heidelberg,
Germany), hydrazine from Merck (Darmstadt, Germany) and aniline
from Riedel-de Haen (Seelze, Germany). All other enzymes and re-
agents were obtained from commercial suppliers.
2.2. Construction of tDNA clones
The templates encoding tRNASer with a UGA anticodon [24] and
tRNASec [18], containing the T7 promoter and a BstNI restriction site,
have been described earlier [25]. All mutated templates derived from
tRNASer or tRNASec were constructed by PCR-based mutagenesis
using appropriate synthetic oligodeoxynucleotides as primers [29]
and were cloned into pUC19. The templates coding for the mini-
and microhelices were directly cloned in pUC19, using full-length
oligodeoxynucleotides, including the T7 promoter and the BstNI re-
striction site. The sequences of all constructs were con¢rmed by di-
deoxy sequencing [30]. ‘U’ mutants are tRNASec derivatives, ‘S’ mu-
tants derive from tRNASer.
2.3. Preparation of tDNA transcripts
Transcription of BstNI-linearized tDNA templates with T7 RNA
polymerase yielded unmodi¢ed tRNAs, which were used for amino-
acylation studies and chemical structure probing. The conditions for
transcription with T7 RNA polymerase were as described by Achsel
and Gross [23]. The resulting tRNAs, containing a correct 3P terminus
(CCA) and a 5P triphosphate, were puri¢ed by gel electrophoresis,
eluted from gel slices with NH4OAc bu¡er [31] and precipitated.
tRNAs and 3P-labelled tRNAs for all following experiments were
denatured by heating for 5 min to 65‡C in 5 mM MgCl2 and cooling
slowly (20 min) to room temperature.
2.4. In vitro aminoacylation
Aminoacylation was performed at 37‡C in 36 Wl containing 100
mM Tris-HCl (pH 7.6), 20 mM KCl, 10 mM MgCl2, 5 mM ATP,
0.5 mM CTP, 0.5 mM DTT, 3.6 Wl cytoplasmic HeLa S100 extract
and 5 WM serine (including 2.5 WM [3H]serine) or 15 WM [3H]serine
(for tRNA mutants with very low aminoacylation e⁄ciency). tRNA
concentrations ranged from 0.3 to 1.5 WM or 15 WM (for those with
very low aminoacylation e⁄ciency). Aliquots of 6 Wl were transferred
onto pieces of glass ¢ber papers which were washed on ice with 10%
and twice with 5% trichloroacetic acid and three times with ethanol to
remove free [3H]serine. Radiolabelled aminoacyl tRNA was then
quantitated by liquid scintillation counting. Apparent KM and Vmax
values were obtained by Lineweaver-Burk analyses of the initial rates
by using ¢ve di¡erent tRNA concentrations [25]. For mutant tRNAs
with very low aminoacylation e⁄ciency, aminoacyl tRNA formation
after 25 min reaction time was measured and percent product forma-
tion was calculated relative to the amount of input RNA.
2.5. Chemical structure probing
tRNAs were labelled with [32P]pCp at their 3P ends [32]. Modi¢ca-
tion at N-3 of cytosine with DMS and N-7 of adenine with DEPC
were performed under native, semi-denaturing and denaturing condi-
tions, respectively. Methylated cytosine bases were cleaved with hy-
drazine at 0‡C. Chain scission was induced by aniline at 60‡C [33].
Control experiments were performed without DMS or DEPC, but
including the same treatment with hydrazine and aniline, respectively.
Additionally, 3P-labelled tRNAs were used for acid cleavage to gen-
erate a ladder for counting nucleotides, and a partial digest with
RNase T1 was performed under denaturing conditions [32]. Reaction
products were analyzed by gel electrophoresis on 10% polyacrylamide/
8 M urea gels and visualized by autoradiography.
3. Results
3.1. Design of tRNASer and tRNASec derivatives
To investigate the contribution of discrete domains of hu-
man tRNASer and tRNASec towards the recognition by hu-
man SerRS and to stabilization of the L-shape, we have con-
structed several mutants of tRNASer and tRNASec (Fig. 1). S-
A and U-A represent the tRNA structure without anticodon
arm, S-E and U-E are constructs with a short extra arm de-
rived from a class I tRNA extra arm consensus, and S-D and
U-D lack the D arm. For the other variants more than one
tRNA domain has been deleted: S-A/E and U-A/E have no
anticodon and extra arm, and S-D/A, U-D/A are lacking the
D and anticodon arm. SMini and UMini are composed of the
acceptor and T stem, the helix being closed with the T loop,
thus comprising one axis of the L-shaped tRNA structure.
The minimal domains of tRNAs used for aminoacylation
are the acceptor stems; the corresponding constructs are
called SMicro and UMicro, respectively. These stems were
extended by an additional C:G base pair in order to mimic
the structural stability of the mature domain, and were con-
nected by the well-characterized UUCG tetraloop [34].
3.2. Aminoacylation kinetics of wildtype tRNASer , tRNASec,
and their variants without anticodon arm (S-A, U-A)
The initial serylation rates of the tRNA variants tRNASer,
tRNASec, S-A, and U-A were determined by aminoacylation
in a HeLa S100 extract as described in Section 2. According
to our recent studies [18] the serine acceptance (relative Vmax/
KM) of tRNASec showed a 10-fold reduction as compared with
tRNASer (Table 1). In order to focus on the contribution of
di¡erent tRNA domains towards the recognition by SerRS,
the in£uence of the anticodon arm in the mutants S-A and U-
A was investigated. Deletion of this domain caused only very
little e¡ect on serine acceptance. KM increases clearly in the
case of S-A and U-A (Table 1) compared with the wildtype
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Table 1
Serylation kinetics of unmodi¢ed tRNASer and tRNASec and derivatives
Substrate App. KM (WM) App. Vmax (WM/min) Vmax/KM (1/min) Rel. Vmax/KM (tRNASer = 1)
tRNASer 0.54 2 3.7 1
S-A 1.1 1.5 1.4 0.38
tRNASec 3.3 1.25 0.4 0.1
U-A 4 1.1 0.3 0.08
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tRNAs; the small di¡erence in the relative Vmax indicates that
the recognition of S-A and U-A is slightly hampered, but the
rate of product formation (Table 2) is nearly the same as for
the wildtype tRNAs. Therefore, whenever a productive inter-
action of the anticodon arm de¢cient mutants with the syn-
thetase has occurred, the enzymatically catalyzed reaction
takes place. Thus we conclude that the anticodon arm of
human tRNASer and tRNASec is not a recognition element
for human SerRS. The in£uence of anticodon arm deletion
on the overall tRNA structure will be discussed later.
3.3. Deletion of any but the anticodon domain of
tRNASer /tRNASec causes a dramatic loss of serine
acceptance
All tRNASer and tRNASec mutants except the S-A/U-A
variants are almost devoid of serine acceptance and it was
impossible to determine the kinetic parameters KM and Vmax
with HeLa S100 extract as synthetase preparation; thus, for
those future experiments, pure human SerRS, which is cur-
rently not available, will be essential. To allow a comparison
between the serine aminoacylation e⁄ciency of the remaining
mutants, the relative product formation after 25 min reaction
time was measured (Table 2). Almost no serine acceptance
was found for the derivatives with a short extra arm, S-E
(0.22%) and U-E (0.57%). For S-A/E (0.21%) and U-A/E
(0.22%) the aminoacylation e⁄ciency was as low as for S-E
and U-E.
The deletion of the D arm alone of tRNASer and tRNASec
(S-D, 4.4%, and U-D, 1.8%), or deletion of the D arm in
combination with the anticodon arm (S-D/A, 3.31%, and U-
D/A, 2.42%) creates mutants which are better substrates for
SerRS than those discussed above, even though they do not
have the L-shaped structure due to the missing D-T loop
interactions.
The derivatives SMini (1.33%), UMini (1.57%), SMicro
(1.31%) and UMicro (1.33%) showed a detectable serine ac-
ceptance, which is nearly identical for these four substrates.
These results lead to the assumption that the minimal required
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Fig. 1. Secondary structure of human tRNASer and tRNASec and their derivatives produced by deletion of secondary structure domains. Terti-
ary interactions identi¢ed by chemical structure probing are indicated by lines. Adenines reactive towards DEPC and cytosines towards DMS
under native conditions are marked: circles = strong, squares = weak reactivity. ‘S’ and ‘U’ identify derivatives of tRNASer and tRNASec, respec-
tively.
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identity element for aminoacylation of tRNASer and tRNASec
comprises the acceptor stem and the discriminator base.
3.4. Chemical structure probing of the tRNA derivatives
containing a D and T arm
We focussed our interest on most of the tertiary interactions
maintaining the L-shape of tRNASer and tRNASec. For this
analysis we chose the modi¢cation at N-3 of cytidine with
DMS and N-7 of adenine with DEPC under native, semi-
denaturing and denaturing conditions [33].
Data of wildtype tRNASer and tRNASec were obtained in
order to compare the results of the chemical structure probing
of tRNASer and tRNASec derivatives (Fig. 1). tRNASer folds
into a tertiary structure built by the following interactions:
the Hoogsteen pairs U8:A14 and U54:A58, the trans
G15:C48 pair, the purine-purine pair G13:A22, and the
G19:C56 base pair. In the anticodon loop C32 and A38 are
protected under native condition, possibly because they form
an unusual base pair or because they are part of a magnesi-
um-binding site [35,36]. For tRNASec the following interac-
tions were detected: the Hoogsteen pairs A8:A14 and
U54:A58, the base pair G19:C56, the standard U26:A44
base pair, and the cis Watson-Crick G45:A48. C32 and A38
showed the same reactivity as in tRNASer. tRNASer deriva-
tives S-E and S-A and tRNASec derivatives U-E and U-A
formed the same tertiary interactions as described for the
wildtype tRNAs and for S-E the additional base pair
G26:A44 was detected which was not visible in the wildtype
tRNASer sequence because of the U at position 44. Taken
together, these results support an L-shaped model for S-E
and U-E and D-T loop interaction for S-A and S-E. In con-
trast to these results, no D-T loop interactions were detected
for the derivatives S-A/E and U-A/E. S-A/E shows only the
U8:A14 and U54:A58 Hoogsteen base pairs and the anom-
alous purine-purine pair G13:A22. Only two tertiary interac-
tions, the Hoogsteen base pairs A8:A14 and U54:A58, occur
in the native structure of U-A/E.
4. Discussion
To advance our knowledge about the contribution of hu-
man tRNASer and tRNASec domains to homologous SerRS
recognition, we constructed several tRNA derivatives. Since
pure human SerRS is not yet available, HeLa S100 extract
was employed for these studies. In order to obtain structural
data for tRNASer/tRNASec derivatives, we used modi¢cation
with DMS at N-3 of cytosine and with DEPC at N-7 of
adenine, which allowed the examination of important tertiary
structural features. We have obtained similar results com-
pared to those investigated for yeast tRNASer [15] and eukary-
otic tRNASec [16,17] for the tertiary features of human
tRNASer and tRNASec (Fig. 1).
We have now determined that the contribution of the anti-
codon arm of tRNASer or tRNASec to SerRS recognition is
negligible. The same conclusion has been drawn for the E. coli
tRNASer-SerRS recognition, where the deletion of the antico-
don arm creates no decrease of serylation [14]. The strongest
evidence that the anticodon arm is no identity element for
SerRS comes from the crystal structure of complexed T. ther-
mophilus tRNASer-SerRS. There the anticodon arm was not
part of the contact regions between tRNA and SerRS [19,20].
As we show here, even for formation of the D-T loop inter-
actions of tRNASer and tRNASec the anticodon arm is not
necessary (Fig. 1).
The extra arm is one of the most important identity ele-
ments of human tRNASer and tRNASec [23,24]. The speci¢c
interaction of E. coli and T. thermophilus SerRS with their
cognate tRNASer depends on the recognition of the backbone
of the long extra arm of tRNASer by the remarkable K-helical
coiled-coil (helical arm) of the synthetase [14,19,20]. The
tRNA derivatives S-E and U-E show almost no serine accept-
ance, even though they contain an L-shaped structure and the
other main identity element of the acceptor stem. Thus, we
propose that human SerRS contains a similar structure for the
speci¢c recognition of the typical long extra arm element of
human tRNASer and tRNASec. The two mutants S-E and U-E
exhibit the same overall structure as class I tRNAs. This may
indicate that human SerRS possibly excludes class I tRNAs,
i.e. the majority of the tRNAs, in the ¢rst step of the recog-
nition process. Small tRNASer and tRNASec derivatives, which
cannot form an L-shaped structure, are still aminoacylated if
they contain the long extra arm as in S-D, U-D, S-D/A and
U-D/A. Like S-E and U-E, the derivatives S-A/E and U-A/E
show almost no serine acceptance. Surprisingly, structure
probing revealed that the D and T loops cannot interact
with each other if both the extra arm and the anticodon
arm are absent, indicating that the remaining stem loops of
these mutants possibly interfere with acceptor stem recogni-
tion by SerRS. In these derivatives special interactions com-
pared to the wildtype tRNAs, which may be important to
form the G19:C56 interaction, were missing. In S-A/E no
G15:C48 base pair was detectable and in U-A/E no
U26:A44 base pair, therefore the G26:U44 base pair in S-
A/E is possibly also absent. The G15 is paired with C48 in
S-E and S-A and the G26:A44 base pair in S-E and possibly
the G26:U44 base pair exists in S-A. In U-E and U-A the
U26:A44 base pair is detectable, suggesting a possible in-
volvement of the 26:44 base pair and of the G15:C48 base
pair in a correct D-T loop interaction (Fig. 1).
To investigate the role of the acceptor stem, the other im-
portant identity element of tRNASer/tRNASec for SerRS rec-
ognition, mini- and microhelices of the two tRNAs were con-
structed and their serine acceptance was determined. For these
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Table 2
Product formation
Substrate Product formation (nM) % Product formation
S-D 660 4.4
S-E 33 0.22
S-D/A 497 3.31
S-A/E 31 0.21
SMini 199 1.33
SMicro 196 1.31
U-D 270 1.8
U-E 86 0.57
U-D/A 363 2.42
U-A/E 33 0.22
UMini 236 1.57
UMicro 199 1.31
tRNASer 999.99 99.99
S-A 958.30 95.83
tRNASec 672.12 67.21
U-A 606.15 60.62
The concentration of RNA in the assay was 1 WM (= 100%) for
tRNASer, S-A, tRNASec and U-A and 15 WM (= 100%) for the remain-
ing derivatives. Product formation was measured after 25 min reaction
time.
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minimal substrates of human SerRS the acceptor stem includ-
ing the discriminator base is the only required identity ele-
ment. However, any microhelix with G in the discriminator
base position does not act as a substrate for human SerRS,
since we have attempted to serylate a microhelix derived from
human tRNALeu with the serine-speci¢c G at the discrimina-
tor base position with no detectable aminoacylation [37].
Nevertheless this G is responsible for a speci¢c destabilization
of the G1:C72 base pair, which is identical in tRNALeu,
tRNASer and tRNASec. Possibly structural features, more
than sequence elements of the acceptor stem, are important
for the recognition by human SerRS, in contrast to the results
obtained for the T. thermophilus and E. coli tRNASer-SerRS
interaction. These structural elements are not only present in
the ¢rst base pair, but also in the remaining acceptor stem.
Sequence comparisons between the acceptor stems of human
tRNASer, tRNASec and tRNALeu show that only the 4:69 base
pair varies between all three tRNAs; in tRNASer it is a G:C,
in tRNASec a C:G and in tRNALeu an A:U pair. For E. coli
tRNASer minihelices, the 4:69 base pair is the major recogni-
tion element in the acceptor stem with G:C and A:U showing
the best serylation results, whereas U:A and C:G decrease
serine acceptance [22]. For human tRNASer/tRNASec-SerRS
interaction the variable 4:69 base pair cannot play a se-
quence-speci¢c role as in E. coli. Possibly, this base pair is
responsible for a structural feature in the microhelices of hu-
man tRNASer/tRNASec which supports SerRS recognition,
and the microhelix of the tRNALeu mutant with G at the
discriminator base position lacks this special structure.
Considering all of the above data, we propose the following
model for tRNA recognition by human SerRS. The enzyme
¢rst screens the overall structure of the tRNAs present in the
cell, excluding all class I tRNAs with short extra arms. Of the
remaining class II tRNAs with long extra arm, tRNALeu is
rejected because of the A in position 73 and of an unfavorable
acceptor arm structure. Finally, the serylation reaction is per-
formed with the remaining tRNAs, tRNASer and tRNASec,
which have the appropriate acceptor stem structure and the
correct discriminator base G.
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